咨詢(xún)熱線
15000266580
15000266580
當(dāng)前位置：首頁(yè) >產(chǎn)品中心>菌種庫(kù)>酵母>伯頓畢赤酵母
簡(jiǎn)要描述：伯頓畢赤酵母， 感謝您使用本單位的微生物菌種，我們有可用于科研、教學(xué)、生產(chǎn)的菌種約2500株，基本覆蓋了環(huán)境、工業(yè)、農(nóng)業(yè)、分析、食、藥用真菌行業(yè)各類(lèi)生產(chǎn)和科研用微生物，其中許多優(yōu)良菌株的生產(chǎn)性能具有較高水平。
產(chǎn)品型號(hào)：廠商性質(zhì)：生產(chǎn)廠家 更新時(shí)間：2025-04-26訪 問(wèn) 量：3694 產(chǎn)品分類(lèi)
Product Category相關(guān)文章
Related Articles詳細(xì)介紹
伯頓畢赤酵母
注意事項(xiàng)
1、 微生物菌種應(yīng)保藏于低溫、清潔和干燥的地方，室溫放置時(shí)間過(guò)長(zhǎng)會(huì)導(dǎo)致菌種衰退；
2、 菌種操作應(yīng)在無(wú)菌條件
進(jìn)行，防止雜菌污染；
3、 斜面菌種保藏時(shí)間通常為3-6個(gè)月，應(yīng)根據(jù)菌種狀況及時(shí)轉(zhuǎn)接；凍干菌種保藏時(shí)間通常為2-15年；
伯頓畢赤酵母下
ATCC® Number: CL-188™
Designations: LS 174T
Depositors: Northwestern University
Biosafety Level: 1
Shipped: frozen
Medium & Serum: See Propagation
Growth Properties: adherent
Organism: Homo sapiens (human)
Morphology: epithelial
Source: Organ: colon
Tumor Stage: Dukes' type B
Disease: colorectal adenocarcinoma
Cellular Products: carcinoembryonic antigen (CEA) (The production of CEA in the ATCC seed stock was 1944 ng per 10(6) cells in 10 days.)
interleukin 10 (IL-10) [22511]
interleukin 6 (IL-6)
mucin
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Tumorigenic: Yes
Reverse Transcript: negative
Oncogene: myc +; myb + ; ras +; fos +; p53 +; sis -; abl -; ros -; src -
Antigen Expression: serologically defined colon cancer antigen 3; Homo sapiens, expressed
HLA A2, B13, B50; Blood type O
Cytogenetic Analysis: 45,X; one X chromosome missing; no other chromosomal aberrations
Isoenzymes: ADA, 1
ES-D, 1
G6PD, B
PEP-D, 1
PGD, A
PGM1, 1
PGM3, 2
Age: 58 years
Gender: female
Ethnicity: Caucasian
Comments: LS 174T is a variant of LS 180 (ATCC CL-187) that has been maintained by using trypsin in the subculture protocol. It is more easily subc*ted than that parent line and, like LS 180, it is reported to produce large amounts of carcinoembryonic antigen (CEA).
Electron microscopic studies revealed abundant microvilli and intracytoplasmic mucin vacuoles [Pubmed ID: 1262041].
They are negative for p53 antigen expression, but positive for mRNA expression.
LS 174T cells stain positively for cytokeratins.
The line is positive for expression of c-myc, N-myc, H-ras, N-ras.
Myb, and fos oncogenes.
K-ras and sis oncogene expression were not detected.
Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Eagle's Minimum Essential Medium, Catalog No. 30-2003. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Temperature: 37.0°C
Subculturing: Protocol:
Remove and discard culture medium.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
Add appropriate aliquots of the cell suspension to new culture vessels.
Incubate cultures at 37°C.
Subc*tion Ratio: A subc*tion ratio of 1:2 to 1:4 is recommended
Medium Renewal: 2 to 3 times per week
Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
Storage temperature: liquid nitrogen vapor phase
Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2003
recommended serum:ATCC 30-2020
derived from same individual:ATCC CL-187
References: 2148: Tom BH, et al. Human colonic adenocarcinoma cells. I. Establishment and description of a new line. In Vitro 12: 180-191, 1976. PubMed: 1262041
3524: Tom BH, et al. Process of producing carcinoembryonic antigen. US Patent 4,228,236 dated Oct 14 1980
22147: Chen TR, et al. Intercellular karyotypic similarity in near-diploid cell lines of human tumor origins. Cancer Genet. Cytogenet. 10: 351-362, 1983. PubMed: 6652615
22511: Gastl GA, et al. Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int. J. Cancer 55: 96-101, 1993. PubMed: 8344757
22861: Trainer DL, et al. Biological characterization and oncogene expression in human colorectal carcinoma cell lines. Int. J. Cancer 41: 287-296, 1988. PubMed: 3338874
32265: Tsao H, et al. Novel mutations in the p16/CDKN2A binding region of the Cyclin-dependent Kinase-4 gene. Cancer Res. 58: 109-113, 1998. PubMed: 9426066
32377: Shibata D, et al. Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation. Nat. Genet. 6: 273-281, 1994. PubMed: 8012390
32794: Kutchera W, et al. Protaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc. Natl. Acad. Sci. USA 93: 4816-4820, 1996. PubMed: 8643486
產(chǎn)品咨詢(xún)
郵箱：xiangfbio@163.com
地址：上海市虹口區(qū)四平路710號(hào)7層
掃一掃 微信咨詢(xún)